HOYA CORPORATION (JP:7741)
:7741
Want to see JP:7741 full AI Analyst Report?
Top Page
HOYA
(7741)
Select Model
Select Model
Rating:83Outperform
Price Target:
¥33,902.00
▲(16.92% Upside)
Action:Reiterated
Date:05/01/26
Strong financial performance (durable profitability, very conservative leverage, and solid cash generation) is the primary driver of the score. Technicals add support with a clear uptrend and positive momentum. Valuation is the main offset, reflecting a moderate premium P/E and low dividend yield.
Positive Factors
Very low leverage
HOYA's extremely low leverage and declining total debt provide durable financial flexibility, lowering insolvency and refinancing risk. This balance sheet strength supports capital allocation for R&D, capex, M&A or buybacks, and helps the company absorb cyclical downturns without stressing operations or liquidity.
Negative Factors
Recent EBIT softness
EBIT decline despite revenue growth signals rising operating costs or margin compression in the core business. If this trend persists, it could erode operating leverage and free cash flow generation, constrain reinvestment capacity, and require margin remediation through pricing, cost cuts, or efficiency initiatives.
Read all positive and negative factors
Positive Factors
Negative Factors
Very low leverage
HOYA's extremely low leverage and declining total debt provide durable financial flexibility, lowering insolvency and refinancing risk. This balance sheet strength supports capital allocation for R&D, capex, M&A or buybacks, and helps the company absorb cyclical downturns without stressing operations or liquidity.
Read all positive factors
HOYA (7741) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥8.83T
Dividend Yield1.01%
Average Volume (3M)1.07M
Price to Earnings (P/E)35.1
Beta (1Y)0.86
Revenue Growth9.44%
EPS Growth28.08%
CountryJP
Employees35,702
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)744.79
Shares Outstanding334,838,000
10 Day Avg. Volume1,057,600
30 Day Avg. Volume1,072,613
Financial Highlights & Ratios
PEG Ratio1.28
Price to Book (P/B)8.85
Price to Sales (P/S)9.53
P/FCF Ratio40.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥31,590.00Price Target Upside8.95% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)799.3
Revenue Forecast (FY)¥1.02T
HOYA Business Overview & Revenue Model
Company Description
Globally recognized as a med-tech innovator, HOYA Corporation is a prominent provider of advanced technology and healthcare solutions worldwide. Its comprehensive portfolio of life care products encompasses vision correction items such as eyeglass...
How the Company Makes Money
HOYA makes money primarily by manufacturing and selling high-value optical and precision products to both consumers (via eye-care channels) and industrial customers (via electronics and semiconductor supply chains). Key revenue streams include: (1...
HOYA Financial Statement Overview
Summary
Income Statement
87
Very Positive
Balance Sheet
93
Very Positive
Cash Flow
90
Very Positive
| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 947.75B | 866.03B | 762.61B | 723.58B | 661.47B |
| Gross Profit | 748.64B | 693.58B | 606.30B | 567.05B | 511.05B |
| EBITDA | 387.88B | 309.48B | 284.45B | 266.20B | 254.48B |
| Net Income | 253.08B | 202.10B | 181.38B | 168.64B | 164.51B |
Balance Sheet | |||||
| Total Assets | 1.30T | 1.23T | 1.20T | 1.03T | 992.84B |
| Cash, Cash Equivalents and Short-Term Investments | 574.09B | 533.97B | 525.16B | 405.89B | 419.40B |
| Total Debt | 42.24B | 37.28B | 29.24B | 24.58B | 21.60B |
| Total Liabilities | 265.89B | 262.65B | 241.36B | 213.72B | 203.78B |
| Stockholders Equity | 1.02T | 974.02B | 967.76B | 818.32B | 803.85B |
Cash Flow | |||||
| Free Cash Flow | 221.87B | 187.19B | 181.73B | 168.36B | 161.18B |
| Operating Cash Flow | 278.45B | 235.11B | 222.80B | 201.83B | 190.06B |
| Investing Cash Flow | -7.59B | -35.82B | -35.81B | -39.93B | -29.13B |
| Financing Cash Flow | -261.26B | -187.72B | -110.89B | -202.16B | -106.89B |
HOYA Technical Analysis
Positive
28995.00
Price Trends
27627.10
Negative
27321.47
Negative
24840.90
Positive
Market Momentum
-480.70
Positive
47.33
Neutral
33.40
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7741, the sentiment is Positive. The current price of 28995 is above the 20-day moving average (MA) of 26455.75, above the 50-day MA of 27627.10, and above the 200-day MA of 24840.90, indicating a neutral trend. The MACD of -480.70 indicates Positive momentum. The RSI at 47.33 is Neutral, neither overbought nor oversold. The STOCH value of 33.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7741.
HOYA Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥8.83T | 35.14 | 25.14% | 1.01% | 9.44% | 28.08% | |
78 Outperform | ¥204.93B | 25.82 | 27.95% | 1.97% | 14.57% | 15.03% | |
76 Outperform | ¥964.45B | 31.49 | 11.64% | 0.82% | 15.13% | 196.11% | |
71 Outperform | ¥3.25T | 23.87 | 8.98% | 1.22% | 9.24% | 16.68% | |
66 Neutral | ¥1.87T | 27.62 | 11.34% | 1.01% | 1.34% | -40.50% | |
54 Neutral | ¥125.17B | 21.64 | 7.81% | 1.78% | 3.39% | 7.21% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
JP:7741
HOYA
26,420.00
10,122.04
62.11%
JP:4543
Terumo
2,199.50
-362.93
-14.16%
JP:7747
Asahi Intecc Co
3,635.00
1,367.87
60.33%
JP:3046
JINS HOLDINGS
8,780.00
663.83
8.18%
JP:7780
Menicon Co
1,645.00
654.81
66.13%
JP:7733
Olympus
1,703.00
-168.57
-9.01%
HOYA Corporate Events
Hoya Ends ¥100 Billion Buyback and Cancels 1.06% of Its Shares
Apr 30, 2026
Hoya Corporation has completed a share repurchase program and decided to terminate the plan ahead of its original schedule, after buying back 3,576,300 common shares for approximately ¥100 billion via market purchases on the Tokyo Stock Excha...
HOYA Sharply Lifts Annual Dividend Forecast for FY2026
Apr 30, 2026
HOYA Corporation has revised its dividend forecast for the fiscal year ended March 31, 2026, signaling stronger shareholder returns in line with its progressive dividend policy. The company now plans a year-end dividend of 170 yen per share, bring...
HOYA Delivers Strong Quarterly Earnings and Boosts Dividend as Cash Flow Surges
Apr 30, 2026
HOYA reported robust growth for the quarter ended March 31, 2026, with revenue rising 14.5% year-on-year to ¥248.1 billion and profit before tax up 14.6%, while maintaining a strong margin above 31%. Profit attributable to owners grew 5.2%, l...
Hoya Weighs Lowering Investment Unit to Broaden Shareholder Base
Apr 10, 2026
Hoya Corporation has outlined its stance on potentially lowering its investment unit size as part of an effort to broaden its investor base and help invigorate the stock market. The company acknowledges that a lower minimum investment could make i...
Hoya Advances Aggressive Share Buyback as March Repurchases Near ¥36 Billion
Apr 1, 2026
Hoya Corporation has reported progress on its ongoing share buyback program authorized by its board in January 2026, executing market purchases of common stock on the Tokyo Stock Exchange. Between March 1 and March 31, the company repurchased 1,29...
HOYA Delays Spin-Off Date for Japanese Endoscope Business to August 2026
Mar 26, 2026
HOYA Corporation has postponed the planned spin-off of its Japanese endoscope business, which is to be transferred via a simplified absorption-type company split to its wholly owned subsidiary PENTAX Medical Corporation. The effective date, initia...
Hoya Corrects Notice on Intervention in Shareholder Derivative Suit
Mar 2, 2026
Hoya Corporation has issued a corrective notice regarding its previously announced intervention in a shareholder derivative lawsuit involving seven current and former directors and executives. The company clarified that its decision to support the...
Hoya Steps Into Shareholder Lawsuit to Support Current and Former Directors
Mar 2, 2026
Hoya Corporation has decided to intervene in a shareholder derivative lawsuit to support seven current and former directors, including its current president and CEO, after a board review concluded they bear no liability for alleged breaches under ...
Hoya Reports Progress on ¥100 Billion Share Buyback Program
Mar 2, 2026
Hoya Corporation has disclosed the latest progress of its ongoing share buyback program authorized by its board on January 30, 2026, under which it is allowed to repurchase up to 5 million shares for a maximum of ¥100 billion through mid-July...
HOYA Faces Shareholder Derivative Suit Over 2016 Share Buyback
Feb 24, 2026
HOYA has disclosed that it was notified of a shareholder derivative lawsuit filed in the Tokyo District Court against seven current and former directors and executive officers. The suit, brought by an individual shareholder, seeks ¥23,624 mil...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.